PMID: 9161801Mar 1, 1997Paper

The treatment of metastatic melanoma with chemotherapy and biologics

Current Opinion in Oncology
M Atkins

Abstract

Metastatic malignant melanoma remains a frustrating and almost invariably fatal disease. Nonetheless, both cytotoxic chemotherapy and immunotherapy agents have shown activity against this disease, and an occasional patient will experience long-term benefit from therapy. Regimens involving various combinations of chemotherapy, the addition of either tamoxifen or interferon alfa have shown promise in phase III trials, but as yet no agent has proven to be superior to single agent dacarbazine alone. Immunotherapy with high-dose interleukin-2, has produced durable complete responses in a small percentage of patients, and combinations of cisplatin-based chemotherapy and interleukin-2-based immunotherapy have produced responses in approximately 50% of patients with 10% durable complete responses. These encouraging results have prompted the design and initiation of several phase III trials comparing various combination biochemotherapy regimens to either chemotherapy or immunotherapy alone. Several new cytotoxic and biologic agents including specific vaccines have recently been investigated, which may add to the therapeutic armamentarium. This article reviews the promising new developments in the treatment of metastatic melanoma, and it...Continue Reading

Citations

Nov 18, 2010·Expert Review of Anticancer Therapy·Esther Erdei, Salina M Torres
Oct 30, 2009·Expert Review of Vaccines·Giulio TostiAlessandro Testori
Nov 8, 2008·Expert Opinion on Biological Therapy·Alessandra di PietroAlessandro Testori
Jan 5, 2002·Expert Opinion on Investigational Drugs·Peter Hersey
Mar 5, 2008·Journal of Clinical Pharmacy and Therapeutics·V GadjevaN Georgieva
Oct 6, 1998·Hematology/oncology Clinics of North America·M B Atkins
Aug 18, 2006·Journal of Translational Medicine·Ruggero RidolfiAngela Riccobon
Jul 26, 2007·BMC Musculoskeletal Disorders·Kuo-Yuan HuangRong-Sen Yang
Jan 11, 2005·Cancer Letters·Byung Chul ParkJung-Ae Kim
Sep 29, 2009·Critical Reviews in Oncology/hematology·Roger MouawadDavid Khayat
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ruggero RidolfiUNKNOWN Italian Melanoma Intergroup
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D BafaloukosP Kosmidis
Jan 1, 2010·Cancers·Kyaw Minn HsanLie-Fen Shyur
Oct 1, 2004·Melanoma Research·Helen GogasAgop Y Bedikian
Sep 13, 2011·Melanoma Research·Laura RidolfiRuggero Ridolfi
Nov 18, 2006·Journal of Clinical Ultrasound : JCU·Yang-Yuan ChenMaw-Soan Soon
Nov 23, 2006·Melanoma Research·Rene GonzalezPaul O Schwarzenberger
Jan 4, 2007·Cancer·Helen J GogasVernon K Sondak
Apr 15, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D BafaloukosH Gogas
Mar 30, 2000·The Journal of Gene Medicine·G Dranoff
May 24, 2001·In Vitro Cellular & Developmental Biology. Animal·L L LicatoE A Grimm
Dec 16, 1998·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·A Spatz, M F Avril
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B E HillnerM R Middleton
Jun 12, 2002·Current Treatment Options in Oncology·W Sun, L M Schuchter
Sep 12, 2017·Lasers in Medical Science·Charles J Puza, Paul J Mosca
Jul 21, 1998·Seminars in Cutaneous Medicine and Surgery·I H Olhoffer, J L Bolognia
Sep 22, 2018·Clinical Journal of Oncology Nursing·Joseph D Tariman

Dec 1, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Klaus EisendleVan Anh Nguyen
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin NeginMichael Atkins
Nov 6, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Caroline ConwayJulia Newton-Bishop
May 14, 2009·Molecular Cancer Research : MCR·Ming ChenSeth J Orlow
Apr 1, 2010·Melanoma Research·Agop Y BedikianRene Gonzalez
Nov 17, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Klaus EisendleVan Anh Nguyen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Control : Journal of the Moffitt Cancer Center
Steven O'DayDouglas S Reintgen
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Sanjiv S Agarwala, John M Kirkwood
Hematology/oncology Clinics of North America
R J Green, L M Schuchter
© 2021 Meta ULC. All rights reserved